Waddell & Reed Financial Inc Purchases 11,300 Shares of Marrone Bio Innovations Inc (MBII) Stock

Marrone Bio Innovations Inc (NASDAQ:MBII) insider Waddell & Reed Financial Inc purchased 11,300 shares of the firm’s stock in a transaction that occurred on Sunday, September 30th. The stock was bought at an average price of $2.77 per share, with a total value of $31,301.00. The acquisition was disclosed in a document filed with the SEC, which is available through this link.

Waddell & Reed Financial Inc also recently made the following trade(s):

  • On Thursday, February 1st, Waddell & Reed Financial Inc sold 800 shares of Marrone Bio Innovations stock. The shares were sold at an average price of $2.11, for a total value of $1,688.00.
  • On Wednesday, June 6th, Waddell & Reed Financial Inc purchased 2,500,000 shares of Marrone Bio Innovations stock. The stock was bought at an average price of $9.50 per share, with a total value of $23,750,000.00.
  • On Wednesday, May 16th, Waddell & Reed Financial Inc purchased 51,788 shares of Marrone Bio Innovations stock. The stock was bought at an average price of $9.25 per share, with a total value of $479,039.00.
  • On Monday, May 14th, Waddell & Reed Financial Inc purchased 16,700 shares of Marrone Bio Innovations stock. The stock was bought at an average price of $9.46 per share, with a total value of $157,982.00.

Shares of Marrone Bio Innovations Inc (NASDAQ MBII) opened at $1.11 on Thursday. Marrone Bio Innovations Inc has a 1 year low of $0.85 and a 1 year high of $2.30. The company has a market capitalization of $34.80, a PE ratio of -0.97 and a beta of 0.26. The company has a debt-to-equity ratio of -1.14, a quick ratio of 0.36 and a current ratio of 0.69.

Marrone Bio Innovations (NASDAQ:MBII) last announced its quarterly earnings data on Monday, November 13th. The basic materials company reported ($0.27) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.24) by ($0.03). equities analysts predict that Marrone Bio Innovations Inc will post -1.01 earnings per share for the current fiscal year.

An institutional investor recently raised its position in Marrone Bio Innovations stock. Ardsley Advisory Partners boosted its holdings in shares of Marrone Bio Innovations Inc (NASDAQ:MBII) by 375.4% in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 3,681,580 shares of the basic materials company’s stock after acquiring an additional 2,907,142 shares during the quarter. Ardsley Advisory Partners owned 11.74% of Marrone Bio Innovations worth $4,528,000 at the end of the most recent quarter. 37.59% of the stock is currently owned by institutional investors and hedge funds.

A number of research firms recently weighed in on MBII. ValuEngine upgraded Marrone Bio Innovations from a “strong sell” rating to a “sell” rating in a research report on Friday, February 2nd. HC Wainwright set a $4.00 price objective on Marrone Bio Innovations and gave the stock a “buy” rating in a research report on Thursday, December 21st. One analyst has rated the stock with a sell rating, three have given a hold rating and one has assigned a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus target price of $2.50.

TRADEMARK VIOLATION NOTICE: This news story was reported by American Banking News and is the property of of American Banking News. If you are accessing this news story on another domain, it was stolen and republished in violation of international copyright and trademark laws. The original version of this news story can be read at https://www.americanbankingnews.com/2018/02/08/waddell-reed-financial-inc-purchases-11300-shares-of-marrone-bio-innovations-inc-mbii-stock.html.

Marrone Bio Innovations Company Profile

Marrone Bio Innovations, Inc offers bio-based pest management and plant health products. The Company’s bio-based products include naturally occurring microorganisms, such as bacteria, fungi and plant extracts. It sells its products to crop protection market. Its four crop protection products include Regalia, Grandevo, Venerate and Majestene.

Insider Buying and Selling by Quarter for Marrone Bio Innovations (NASDAQ:MBII)

Receive News & Ratings for Marrone Bio Innovations Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marrone Bio Innovations and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply